American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis
BK Tan, S Mainbourg, A Friggeri, L Bertoletti… - Thorax, 2021 - thorax.bmj.com
Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review
SV Sylvester, R Rusu, B Chan, M Bellows… - Current Medical …, 2022 - Taylor & Francis
Objective We conducted literature reviews to uncover differential effects of sex on sequelae
from coronavirus disease 2019 (COVID-19) and on long COVID syndrome. Methods Two …
from coronavirus disease 2019 (COVID-19) and on long COVID syndrome. Methods Two …
Venous thromboembolism in COVID-19: A systematic review and meta-analysis
Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …
thromboembolism events (VTE). This study performed a systematic review in …
Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management
L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - Am Heart Assoc
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …
Pulmonary thrombosis and thromboembolism in COVID-19
HD Poor - Chest, 2021 - Elsevier
COVID-19, the disease responsible for the devastating pandemic that began at the end of
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity
EG Bouck, F Denorme, LA Holle… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Coronavirus disease 2019 (COVID-19) is associated with derangement in
biomarkers of coagulation and endothelial function and has been likened to the …
biomarkers of coagulation and endothelial function and has been likened to the …
Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …
pandemic, and patients with the infection are referred to as having COVID‐19. Although …
[HTML][HTML] COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women's …
Abstract Background Novel coronavirus (SARS‐CoV‐2), which causes COVID‐19, has thus
far affected more than 15 million individuals, resulting in more than 600 000 deaths …
far affected more than 15 million individuals, resulting in more than 600 000 deaths …